homepage top section
No drugs for prions: could new approaches alleviate therapeutic scarcity?
The development of therapeutics for transmissible spongiform encephalopathies (TSEs) continues to be challenged by the complex nature of these diseases.…
How close are we to getting a male contraceptive?
With advances in clinical studies evaluating male contraceptives, and laws restricting abortion access after Roe v. Wade was overturned in…
Alopecia: Can new treatments pass the innovation and safety bar?
Last Friday, the US FDA decided to keep the popular anti-baldness drug finasteride on the market, but is now requiring…
The opioid epidemic: is pharma doing enough to develop treatments for the crisis?
The unique needs of an ongoing opioid crisis have pushed researchers to innovate while developing approaches to treat substance use…
Continuous manufacturing builds on hype but adoption remains gradual
The enthusiasm to build strong, sustainable supply chains only has only increased in the last few years following Brexit and…
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
Covid-19 patent lawsuits: Will vaccine producers have to pay the bill?
In a new chapter with emerging legal dimensions for the Covid-19 vaccine success story, last week Moderna submitted a filing…
Access to CAR-T therapies in Central and Eastern Europe in “catch-up” mode compared to the West
Certain EU member states in Central and Eastern Europe still struggle to access chimeric antigen receptor (CAR)-T cell therapies compared…